杭华股份：2025年前三季度净利润约7594万元

Group 1 - Company Hanghua Co., Ltd. reported third-quarter performance with revenue of approximately 907 million yuan, a year-on-year decrease of 1.62% [1] - The net profit attributable to shareholders of the listed company was about 75.94 million yuan, reflecting a year-on-year decline of 25% [1] - Basic earnings per share stood at 0.18 yuan, also down by 25% compared to the previous year [1] Group 2 - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market's activity, which is thriving, while the primary market is experiencing a fundraising slowdown [1]